Market revenue in 2023 | USD 39.8 million |
Market revenue in 2030 | USD 65.9 million |
Growth rate | 7.5% (CAGR from 2023 to 2030) |
Largest segment | Quantitative |
Fastest growing segment | Digital |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Quantitative, Digital, End-point |
Key market players worldwide | Abbott Laboratories, Qiagen NV, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Thermo Fisher Scientific Inc, GE Aerospace, BioMerieux SA, Roche Holding AG ADR, Fluidigm Corporation |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to real time pcr, digital pcr, and end point pcr market will help companies and investors design strategic landscapes.
Quantitative was the largest segment with a revenue share of 80.65% in 2023. Horizon Databook has segmented the South Africa real time pcr, digital pcr, and end point pcr market based on quantitative, digital, end-point covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa has a high burden of infectious diseases, such as HIV/AIDS and tuberculosis. The country has a large population prone to these diseases and requires focused detection tests & treatment. The increasing mortality rates and healthcare expenditures by government & private entities are expected to drive the market.
Moreover, the rise in mortality and morbidity rates is anticipated to increase the prevalence of diseases, resulting in the high use of PCR products. Furthermore, the South African government collaborated with the UNO to improve healthcare measures to decrease mortality and increase life expectancy.
The rise in the prevalence of cancer in South Africa has led to an increase in the need for advanced genomics techniques to detect cancer. According to Lancet, a medical journal, South Africa will witness a 78% increase in cancer cases by 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa real time pcr, digital pcr, and end point pcr market , including forecasts for subscribers. This country databook contains high-level insights into South Africa real time pcr, digital pcr, and end point pcr market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account